STOCK TITAN

Medical Care Technologies Inc. (OTC Pink:MDCE) Signals Long-Term Potential to Redefine Consumer Dermatology Standards Through AI

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
AI

Medical Care Technologies (OTC PINK: MDCE) described a long-term strategy to embed AI-driven skin monitoring into consumer health routines, positioning continuous visual tracking as a preventive tool for conditions such as melanoma, basal cell carcinoma, and squamous cell carcinoma. MDCE is finalizing an Android build of its first AI lifestyle app, with an announcement and launch expected in the coming weeks.

The company emphasizes scalable AI infrastructure, longitudinal data continuity, and consumer-accessible platforms to support early awareness, follow-up triage, and potential future medical pre-screening applications.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

MESA, ARIZONA / ACCESS Newswire / February 5, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today outlined its long-term vision to help redefine consumer dermatology standards through the regular use of advanced artificial intelligence technologies designed to make routine skin monitoring as commonplace as fitness and wellness tracking.

As consumer health continues to shift toward prevention, personalization, and data-driven insights, MDCE is positioning itself at the intersection of computer vision, machine learning, and dermatological surveillance. The Company believes that the future of skin health lies not in isolated, one-time evaluations, but in continuous, longitudinal monitoring that can intelligently track visible changes across the skin over time.

MDCE's ongoing development efforts are centered around AI-powered solutions capable of analyzing routine skin images to detect subtle changes in size, shape, color, and pattern-changes that may be imperceptible to the naked eye but meaningful from a long-term health perspective. By creating a visual history of skin changes, these technologies have the potential to enhance early awareness of conditions such as melanoma, basal cell carcinoma, and squamous cell carcinoma, while supporting more informed follow-up and triage decisions.

"Just as wearable technology transformed how people understand their physical activity and cardiovascular health, we believe AI-driven skin monitoring represents the next frontier in consumer preventive care," said Marshall Perkins, CEO of Medical Care Technologies Inc. "Our goal is to help empower individuals with tools that bring visibility, continuity, and intelligence to something that has historically been episodic and reactive."

While clinical dermatology tools for lesion analysis exist today, MDCE sees a significant opportunity in building consumer-accessible platforms that integrate full-body monitoring and longitudinal data tracking-an area that remains largely underserved and presents meaningful intellectual property and market capture potential.

This strategic vision aligns with MDCE's broader roadmap across AI-based lifestyle, wellness, and medical pre-screening applications. The Company continues to advance development efforts while finalizing the Android build of its first AI-based lifestyle application, which is expected to be announced and launched in the coming weeks.

By focusing on scalable AI infrastructure, data continuity, and preventive health engagement, MDCE believes it is laying the groundwork for long-term value creation in a global market increasingly defined by proactive, technology-enabled healthcare solutions.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC PINK:MDCE) is a technology-driven company focused on developing artificial intelligence-powered mobile applications across lifestyle, wellness, and medical pre-screening categories. Through its subsidiaries, the Company also operates in high-value authentication, collectibles, and digital marketplaces, leveraging proprietary AI and data-driven methodologies to unlock new growth opportunities.
www.medicalcaretechnologies.com

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Medical Care Technologies Inc. undertakes no obligation to update or revise any forward-looking statements except as required by law.

Media & Investor Inquiries

Medical Care Technologies Inc. (OTC PINK:MDCE)
www.medicalcaretechnologies.com
Email: info@infiniteauctions.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)



View the original press release on ACCESS Newswire

FAQ

What is MDCE announcing about AI-driven skin monitoring on February 5, 2026?

MDCE announced a strategic focus on continuous AI-powered skin monitoring for consumers. According to the company, the goal is to enable longitudinal tracking of skin changes to support earlier awareness of conditions like melanoma and to improve follow-up and triage decisions.

When will Medical Care Technologies (MDCE) launch its first AI-based lifestyle app on Android?

MDCE expects to announce and launch its Android build in the coming weeks. According to the company, the Android build is being finalized and will be the first AI lifestyle application in its roadmap toward consumer-accessible skin monitoring.

How could MDCE's AI solutions affect early detection of skin cancers for consumers?

MDCE says its AI analyzes routine skin images to detect subtle changes in size, shape, color, and pattern. According to the company, this longitudinal visual history may help increase early awareness of melanoma, basal cell carcinoma, and squamous cell carcinoma for follow-up decisions.

What technology areas is MDCE combining to build its consumer dermatology platform (MDCE)?

MDCE is integrating computer vision, machine learning, and dermatological surveillance into its platform. According to the company, this combination aims to provide continuous, data-driven skin monitoring and support preventive, personalized health engagement for consumers.

What is the investor implication of MDCE's roadmap toward AI-based preventive skin health?

MDCE positions its roadmap as groundwork for long-term value creation through scalable AI infrastructure and data continuity. According to the company, the strategy targets consumer preventive care markets rather than immediate revenue metrics or near-term financial guidance.
Medical Care Technologies Inc

OTC:MDCE

MDCE Rankings

MDCE Latest News

MDCE Stock Data

1.11M
Internet Retail
Consumer Cyclical
Link
United States
Mesa